Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
TV & Film
Technology
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts116/v4/1f/03/2f/1f032fb1-733f-5287-6afc-a28f9ab6ce10/mza_4527214507306323643.jpg/600x600bb.jpg
PeerVoice Oncology & Haematology Audio
PeerVoice
138 episodes
2 weeks ago
PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
Show more...
Science
Education,
How To,
Health & Fitness,
Medicine
RSS
All content for PeerVoice Oncology & Haematology Audio is the property of PeerVoice and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
Show more...
Science
Education,
How To,
Health & Fitness,
Medicine
https://is1-ssl.mzstatic.com/image/thumb/Podcasts116/v4/1f/03/2f/1f032fb1-733f-5287-6afc-a28f9ab6ce10/mza_4527214507306323643.jpg/600x600bb.jpg
Erika Hamilton, MD - Safety First: Recognising and Responding to Toxicities Associated With TROP2-Directed Therapies in Metastatic Breast Cancer
PeerVoice Oncology & Haematology Audio
19 minutes 54 seconds
11 months ago
Erika Hamilton, MD - Safety First: Recognising and Responding to Toxicities Associated With TROP2-Directed Therapies in Metastatic Breast Cancer
Visit https://www.peervoice.com/YVF860 to view the entire programme with slides. After completing “Erika Hamilton, MD - Safety First: Recognising and Responding to Toxicities Associated With TROP2-Directed Therapies in Metastatic Breast Cancer”, participants will be able to: Identify common adverse events associated with the use of TROP2-directed agents in the management of advanced breast cancer; and Implement evidence-based best practices in the monitoring, identification, and management of adverse events in patients with advanced breast cancer receiving TROP2-directed therapy.
PeerVoice Oncology & Haematology Audio
PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.